Gapping down
In reaction to disappointing earnings/guidance: MEP -30.5%, RAX -15.5%,FULL -13.2%, CERN -12.5%, EEP -11.2%, MXWL -8.6%, VDSI -6.6%, ACHC-5.5%, LPI -4%, ZIXI -3.3%, DVN -2.4%, ADI -2.1%, AJRD -1.4%, HLIT -1.2%,GEO -0.9%, DPS -0.9%, ENLK -0.7%, ESRX -0.6%, HST -0.6%, CLMT -0.5%
Other news: CPRX -50.3% (receives a 'Refusal to File' letter from the FDA regarding its NDA for Firdapse; plans to request meeting w/ FDA to discuss),GRPN -2.9% (modestly pulling back following yesterday's strength), CYH-2.2% (cont weakness), POT -1% (still checking), RCL -0.9% (Tremblant Capital Group discloses reduced position)
Analyst comments: KKR -2.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley), BTU -3% (downgraded to Neutral from Buy at Sterne Agee CRT)
In reaction to disappointing earnings/guidance: MEP -30.5%, RAX -15.5%,FULL -13.2%, CERN -12.5%, EEP -11.2%, MXWL -8.6%, VDSI -6.6%, ACHC-5.5%, LPI -4%, ZIXI -3.3%, DVN -2.4%, ADI -2.1%, AJRD -1.4%, HLIT -1.2%,GEO -0.9%, DPS -0.9%, ENLK -0.7%, ESRX -0.6%, HST -0.6%, CLMT -0.5%
Other news: CPRX -50.3% (receives a 'Refusal to File' letter from the FDA regarding its NDA for Firdapse; plans to request meeting w/ FDA to discuss),GRPN -2.9% (modestly pulling back following yesterday's strength), CYH-2.2% (cont weakness), POT -1% (still checking), RCL -0.9% (Tremblant Capital Group discloses reduced position)
Analyst comments: KKR -2.1% (downgraded to Equal-Weight from Overweight at Morgan Stanley), BTU -3% (downgraded to Neutral from Buy at Sterne Agee CRT)